Iranian Journal of Pharmaceutical Research

1. A 99mTc-tricine-HYNIC-labeled Peptide Targeting the Melanocortin-1 Receptor for Melanoma Imaging

Volume 15, Issue 3, Summer 2016, Pages 349-360

Danial Shamshirian; Mostafa Erfani; Davood Beiki; Maliheh Hajiramazanali; Babak Fallahi

View Article
PDF 1019.95 K

2. Synthesis and Preliminary Evaluation of a New 99mTc Labeled Substance P Analogue as a Potential Tumor Imaging Agent

Volume 14, Issue 1, Winter 2015, Pages 97-110

Saeed Mozaffari; Mostafa Erfani; Davood Beiki; Fariba Johari Daha; Farzad Kobarfard; Saeed Balalaie; Babak Fallahi

View Article
PDF 1011.57 K

3. 99mtc-Ubiquicidin [29–41], a Promising Radiopharmaceutical to Differentiate Orthopedic Implant Infections from Sterile Inflammation

Volume 12, Issue 2, Spring 2013, Pages 347-353

Davood Beiki; Gholamali Yousefi; Babak Fallahi; Mohammad Naghi Tahmasebi; Ali Gholamrezanezhad; Armaghan Fard-Esfahani; Mostafa Erfani; Mohammad Eftekhari

View Article
PDF 564.88 K

1. A 99mTc-tricine-HYNIC-labeled Peptide Targeting the Melanocortin-1 Receptor for Melanoma Imaging

2. Synthesis and Preliminary Evaluation of a New 99mTc Labeled Substance P Analogue as a Potential Tumor Imaging Agent

3. 99mtc-Ubiquicidin [29–41], a Promising Radiopharmaceutical to Differentiate Orthopedic Implant Infections from Sterile Inflammation

Journal Archive